Apotex Pays $24.1M, Enters Deferred Prosecution Pact For Drug Price Conspiracy
PHILADELPHIA — Generic drug manufacturer Apotex Corp. on May 7 agreed to pay a $24.1 million penalty and to enter into a deferred prosecution agreement with the U.S. Justice Department for...To view the full article, register now.
Already a subscriber? Click here to view full article